BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23348850)

  • 1. [Diabesity and cardiovascular diseases: Novel mediators and novel targets].
    Stoclet JC
    Ann Pharm Fr; 2013 Jan; 71(1):4-6. PubMed ID: 23348850
    [No Abstract]   [Full Text] [Related]  

  • 2. Autonomic neuropathy in type II diabetes mellitus: the influence of obesity.
    Neil HA; Thorogood M
    J Intern Med; 1990 Sep; 228(3):293. PubMed ID: 2401880
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of blood pressure on the risk for cardiovascular diseases: what should be done now?
    Wang Y
    Am J Hypertens; 2008 Mar; 21(3):247. PubMed ID: 18311124
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus".
    Deedwania PC
    Arch Intern Med; 2010 Sep; 170(17):1575-7. PubMed ID: 20876409
    [No Abstract]   [Full Text] [Related]  

  • 6. Obesity and metabolic disease.
    Koopman RJ; Swofford SJ; Beard MN; Meadows SE
    Prim Care; 2009 Jun; 36(2):257-70. PubMed ID: 19501242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quantification of cardiovascular risk factors in subjects with/without diabetes mellitus.
    Pănuş C; Răducanu CL; Mota M
    Rom J Intern Med; 2004; 42(2):355-70. PubMed ID: 15529626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH; Hardisty CA
    QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking our approach to the obese patient: time to create the obesity treatment score.
    Mechanick JI; Apovian CM
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):339-40. PubMed ID: 22892868
    [No Abstract]   [Full Text] [Related]  

  • 10. Focus on metformin - a major cardiovascular medication. 'Diabesity - the biggest epidemic in human history'.
    Straughan JL
    Cardiovasc J Afr; 2007; 18(5):331-3. PubMed ID: 17985034
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiologists and abdominal obesity: lost in translation?
    Poirier P
    Heart; 2009 Jul; 95(13):1033-5. PubMed ID: 19398438
    [No Abstract]   [Full Text] [Related]  

  • 12. Summaries for Patients. The Obesity Paradox in Type 2 Diabetes Mellitus.
    Ann Intern Med; 2015 May; 162(9):I-26. PubMed ID: 26146667
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered plasma adipokines and markers of oxidative stress suggest increased risk of cardiovascular disease in First Nation youth with obesity or type 2 diabetes mellitus.
    Stringer DM; Sellers EA; Burr LL; Taylor CG
    Pediatr Diabetes; 2009 Jun; 10(4):269-77. PubMed ID: 19175895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The importance of overweight and obesity for the development and progression of renal diseases].
    Klassen A; Bahner U; Sebekova K; Heidland A
    Dtsch Med Wochenschr; 2004 Mar; 129(11):579-82. PubMed ID: 14997412
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I; Goldstein BJ
    Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of obesity: impact on diabetes and other comorbidities.
    Pontiroli AE
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):1-6. PubMed ID: 17467961
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetology 2007].
    Scherbaum WA
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1407-10. PubMed ID: 17570091
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of body iron stores and the prevention of type 2 diabetes.
    Mascitelli L; Pezzetta F
    Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
    [No Abstract]   [Full Text] [Related]  

  • 20. [From bench to bed side:a splendid route fraught with difficulties].
    Laguna Egea JC
    Clin Investig Arterioscler; 2014; 26(6):285-6. PubMed ID: 25457351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.